The United States Pharmacopoeia has released the most current proposed version of chapter 797.
INDIANAPOLIS, Sept. 26, 2018 /PRNewswire/ — Containment Technologies Group, Inc. www.mic4.com is the premier leader in innovative technology solutions for your aseptic compounding needs. Our MIC Family of Products have been providing cutting edge solutions for all of your compounding needs for more than 25 years. Our newest product, the MIC-EDU, is the first compounding aseptic isolator to use vapor-phase hydrogen peroxide (VHP) to offer the highest levels of sterility assurance in the industry.
We are your complete resource for your USP 797 and 800 needs. We not only provide primary engineering control solutions, but we also offer services such as training, maintenance programs, supply department, and a full complement of certification services.
We are known for innovative products, top-tier customer service, and the ability to adapt to the ever-changing regulatory environment.
Containment Technologies Group, Inc. is your source for subject matter expertise in navigating the regulatory environment. Our team of industry experts have decades of experience with working with USP, State Boards of Pharmacy, and the FDA. USP has recently released its most current version of chapter 797. Please come and visit our resources page on our website to learn more about the changes, how they affect you, and our easy guide on interpreting the new proposed regulations. The below hyperlink will take you directly to our most recent power point presentation that is used in our Containment Technologies Group, Inc. Training Academy.
https://www.mic4.com/wp-content/uploads/2018/09/Proposed-USP797-Powerpoint-Summary.pdf